Latest Whitepapers

In this article to learn more about detecting contamination during bioprocessing, contamination’s influence on product quality and safety and emerging methods for detecting microbial contaminations.

This article discusses the use of nanoparticle-based lateral flow assays (LFAs) to detect mycotoxins, enhancing sensitivity, accuracy and speed.

Discover cutting-edge whole-genome sequencing technology that offers unparalleled accuracy and completeness in microbial genome assembly, providing essential insights into pathogen surveillance and antimicrobial resistance.

This whitepaper explores the need for transparency between suppliers and manufacturers, ensuring the integrity of their products and maintaining trust among consumers and regulatory authorities alike.

This whitepaper explores the tools available to characterize antibody binding to Fc receptors, including quantitative assays to support optimization of therapeutic products.

Binding affinity is a significant factor to consider. However, relying solely on affinity can be problematic, as the highest affinity mAbs may not exhibit optimal activity. To ensure the best lead candidates, it is crucial to consider factors like specificity, selectivity and biological relevance.

This article explores how scientists are tackling the challenges and intensifying efforts to develop mRNA therapeutics for different diseases.

This whitepaper explores the key steps in the antibody development process and highlights how partnership with an expert manufacturing service provider can help to simplify and expedite your workflow.

In this interview, delve into the significance of measuring immune mediators with high sensitivity, revolutionizing our understanding of disease dynamics.

Genomics, proteomics and microbiomics are all useful tools in complex disease research. However, using these tools alone can risk critical knowledge gaps and leave researchers struggling to predict disease outcomes.